Chapter 49: Problem 5
What is the difference between biomarker and risk marker?
Short Answer
Step by step solution
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
Chapter 49: Problem 5
What is the difference between biomarker and risk marker?
These are the key concepts you need to understand to accurately answer the question.
All the tools & learning materials you need for study success - in one app.
Get started for freeWhat are biomarkers and how are they identified and validated for use in the clinical setting?
Major difficulty in proteomic studies of certain type of samples such as CSF: a. contamination with drugs penetrating through blood brain barrier b. size and availability of the sample c. lack of correlation with clinical diagnosis d. contamination with red blood cells during spinal \(\operatorname{tap}\)
While planning proteomics experiments, a researcher should: a. have available all types of mass spectrometers b. mandatory access to protein microarrays c. be aware of strength and weaknesses of each technology d. always be an expert in statistics and computer programming for solving problems associated with bioinformatics
Top-down approach in studies of systems biology is preferential over bottom-up approach because: a. it provides more global view b. it allows for faster conclusions which will lead to direct development of clinical tests c. requires less sophisticated technology and instrumentation d. both approaches are equal
Explain in which cases SELDI-TOF technology will be more advantageous than LC- MS/MS and/or MALDI-TOF.
What do you think about this solution?
We value your feedback to improve our textbook solutions.